Heightened TLR7 signaling primes BCR-activated B cells in chronic graft-versus-host disease for effector functions.

Authors:
Bracken SJ; Suthers AN; DiCioccio RA; Su H; Anand S and 14 more

Journal:
Blood Adv

Publication Year: 2024

DOI:
10.1182/bloodadvances.2023010362

PMCID:
PMC10839617

PMID:
38113462

Journal Information

Full Title: Blood Adv

Abbreviation: Blood Adv

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Hematology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict-of-interest disclosure: The authors declare no competing financial interests."

Evidence found in paper:

"This work was supported by National Institutes of Health grant R01HL129061 (National Heart, Lung, and Blood Institute; S.S.), an ASBMT Young Investigator award (A.S.), 1R38AI40297 (S.J.B.), and European Union’s Horizon 2020 Research and Innovation Program under the Marie Sklodowska-Curie grant agreement No 888743 (J.V. and S.S.)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025